Childhood asthma and Covid 19
Asthma Allergy Immunology
; 18:11-14, 2020.
Article
in English
| EMBASE | ID: covidwho-2320055
ABSTRACT
Coronavirus disease 2019 (Covid 19) is caused by the severe acute respiratory syndrome coronavirus-2 (SARS CoV 2) and causes lymphopenia, immunosuppression, inefficient T and B cell immunity, cytokine storm, and destructive tissue inflammation. Since COVID 19 is a multi-system disease predominantly affecting the lungs, there is doubt on whether chronic lung diseases place patients at higher risk and SARS CoV2 leads to asthma exacerbation. None of the studies have reported asthma or recurrent wheezing as a comorbidity or risk factor for Covid 19 in children up to now. Notably, further studies are needed to explore the relationship between Covid 19 and asthma to improve clinical practice and decrease morbidity and mortality.Copyright © 2020 Bilimsel Tip Yayinevi. All rights reserved.
Asthma; Children; Covid 19; SARS CoV 2; asthma/dt [Drug Therapy]; clinical practice; coronavirus disease 2019; corticosteroid therapy; disease association; human; morbidity; mortality; pediatric patient; priority journal; review; angiotensin converting enzyme 2/ec [Endogenous Compound]; coronavirus spike glycoprotein/ec [Endogenous Compound]; corticosteroid/dt [Drug Therapy]; corticosteroid/ih [Inhalational Drug Administration]; corticosteroid/pv [Special Situation for Pharmacovigilance]; transmembrane protease serine 2/ec [Endogenous Compound]
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Language:
English
Journal:
Asthma Allergy Immunology
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS